HEOR
Jenny Lee is a seasoned professional with extensive experience in market access, health technology assessments, medical education, and scientific publishing. Currently serving as a Principal Portfolio Consultant at HEOR since September 2022, Jenny previously held various roles at Clarivate from January 2016 to July 2022, including Director of Health Technology Assessment, Senior Consultant, and Consultant. Prior experience includes roles as Account Manager and Project Manager at Hayward Medical Communications from August 2012 to January 2016, and an Industrial Placement Student at AstraZeneca's Oncology Targets Validation Team from September 2009 to September 2010. Jenny Lee earned a degree in Biological Sciences with a focus on Mass Spectrometry from the University of Cambridge and a degree in Biochemistry with employment experience from The University of Sheffield.
This person is not in any teams
HEOR
Established in 2011, HEOR is a leading independent market access consultancy with a reputation for high-quality, innovative market access strategies, evidence generation and value communications. We are a team of over 90 consulting and research professionals based in the UK and Germany and our expertise spans market access strategy, health economics, health technology assessments, pricing and reimbursement, data science and analytics, systematic literature reviews, evidence generation, medical writing, stakeholder engagement and value communication. We have a global presence and work across the UK, Europe, US, Canada, Asia-Pacific and the Middle East to provide a fully integrated market access service across the product life-cycle. HEOR Ltd acts as a trusted partner to the world’s major pharmaceutical and biopharmaceutical companies. Our clients value our flexibility, integrity to scientific principles and best practice and our ethos of true partnership, where our track record speaks to deep and continuing client collaborations, across all disease areas and service offerings.